Call Options

9 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$143.31 - $247.0 $3.07 Million - $5.29 Million
21,400 Added 62.94%
55,400 $13.5 Million
Q1 2024

May 15, 2024

SELL
$146.51 - $198.2 $835,107 - $1.13 Million
-5,700 Reduced 14.36%
34,000 $5.08 Million
Q4 2023

Feb 14, 2024

BUY
$151.41 - $196.57 $6.01 Million - $7.8 Million
39,700 New
39,700 $7.6 Million
Q3 2022

Nov 14, 2022

SELL
$138.54 - $232.0 $207,810 - $348,000
-1,500 Reduced 4.13%
34,800 $6.97 Million
Q2 2022

Aug 15, 2022

BUY
$120.42 - $169.29 $2.47 Million - $3.47 Million
20,500 Added 129.75%
36,300 $5.29 Million
Q1 2022

May 16, 2022

SELL
$127.18 - $173.91 $496,002 - $678,249
-3,900 Reduced 19.8%
15,800 $2.58 Million
Q4 2021

Feb 14, 2022

BUY
$159.56 - $209.29 $303,164 - $397,651
1,900 Added 10.67%
19,700 $3.34 Million
Q3 2021

Nov 15, 2021

SELL
$169.75 - $207.73 $712,950 - $872,466
-4,200 Reduced 19.09%
17,800 $3.36 Million
Q2 2021

Aug 16, 2021

BUY
$128.63 - $176.89 $2.83 Million - $3.89 Million
22,000 New
22,000 $3.73 Million

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $29.9B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.